Clinical Trial Update: Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing Surufatinib plus chemotherapy versus Surufatinib alone in patients with pulmonary neuroendocrine tumors is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Neuroendocrine Tumor

Drugs mentioned

• Chemotherapy (chemotherapy)
• Surufatinib (Surufatinib)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Pulmonary Neuroendocrine Tumor | Phase 2 | Status: RECRUITING